Phaclofen

From WikiMD's WELLNESSPEDIA

Phaclofen is a GABAB receptor antagonist drug that was first described in the literature in 1981. It is used in scientific research and has no known therapeutic use in humans.

History[edit]

Phaclofen was first described in the literature in 1981. It was developed as a research tool for studying the GABAB receptor, a type of G protein-coupled receptor that is found in the brain and spinal cord. The GABAB receptor is involved in a variety of physiological processes, including inhibition of neuronal activity and modulation of neurotransmitter release.

Pharmacology[edit]

Phaclofen acts as an antagonist at the GABAB receptor, meaning that it blocks the action of the neurotransmitter gamma-aminobutyric acid (GABA) at this receptor. This makes it a useful tool for studying the role of the GABAB receptor in various physiological processes.

Research Use[edit]

Phaclofen has been used in a variety of research studies to investigate the role of the GABAB receptor in the brain and spinal cord. For example, it has been used to study the role of this receptor in pain perception, memory formation, and the regulation of mood and anxiety.

See Also[edit]

References[edit]


Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.



  • Phaclofen
    Phaclofen

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Phaclofen&oldid=6495955"